DEFINITIVE PROXY STATEMENT

Company

Anika Therapeutics, Inc.

Filed

April 23, 2014

Period of Report

June 5, 2014

Accession Number

0001171843-14-001810

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →